Full access to Entrepreneur for $5

FDA Grants First Full Approval of COVID-19 Vaccine

FDA Grants First Full Approval of COVID-19 Vaccine.

This story originally appeared on Zacks

Don’t look now, but we’re riding a three-day winning streak on the S&P 500: after a couple weeks of slogging through a strong Q2 earnings season on fears of the Delta variant closing down the economy again, we now see FDA approval for the Pfizer PFE vaccine and a fresh attitude toward the stock market. The Nasdaq is up three straight sessions as well, and has registered its first all-time closing high for the first time since August 5th.

For the Dow, it remains below all-time highs by roughly 0.8% this morning, and it is up two straight days. Currently, the Dow looks to open Tuesday’s session +50 points, the S&P 500 +4 points and the Nasdaq +15. We are also at the brink of a quiet period at the end of Q2 earnings season but prior to Labor Day; summertime only has a short window to take advantage of from here.

Aside from Covid concerns and the Delta variant, another big story hitting the market has been the harsh crackdown from the Chinese government on Chinese tech companies that appears to be growing too big and powerful for the central government to control outright. A bit of equilibrium may be forthcoming, however: Chinese tech has rallied of late, with Pinduoduo PDD up +11.8% today and JD.com JD +9%.

After the opening bell, we expect a new report on New Home Sales for July, where it is estimated 700K seasonally adjusted, annualized units will have been made last month. This would be an uptick from the 676K reported for June; these monthly figures had been falling every month since the 873K reported back in March. In January of this year, we saw nearly 1 million new homes sold. But supply constraints and subsequent high prices have thrown a wet blanket on the housing industry.

Ahead of today’s open, Best Buy BBY outperformed expectations by a wide margin on both earnings and sales, with $2.98 per share easily shattering the $1.91 in the Zacks consensus, on $11.85 billion in revenues topping the $11.60 billion expected and up almost 20% year over year. Same-store sales also grew 20%, led by a 242% gain in online sales year over year.

Even in these challenging times for retail going back a year and a half, Best Buy has only missed earnings expectations once in the past five years. But the reason the stock has popped more than 4% on its earnings news this morning is in the upward revenue guidance for next quarter ($11.4-11.6 billion versus $10.49 billion consensus) and full year ($51-52 billion versus $49.56 billion consensus). Shares are still lagging the S&P year to date.

- Zacks

Tech IPOs With Massive Profit Potential

In the past few years, many popular platforms and like Uber and Airbnb finally made their way to the public markets. But the biggest paydays came from lesser-known names.

For example, electric carmaker X Peng shot up +299.4% in just 2 months. Think of it this way…

If you had put $5,000 into XPEV at its IPO in September 2020, you could have cashed out with $19,970 in November.

With record amounts of cash flooding into IPOs and a record-setting stock market, this year’s lineup could be even more lucrative.

See Zacks Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


Pfizer Inc. (PFE): Free Stock Analysis Report


Best Buy Co., Inc. (BBY): Free Stock Analysis Report


JD.com, Inc. (JD): Free Stock Analysis Report


Pinduoduo Inc. Sponsored ADR (PDD): Free Stock Analysis Report


To read this article on Zacks.com click here.